CDXS News and Press, Codexis Inc. From 01/23/23

Enzyme engineering company Codexis ( NASDAQ: CDXS ) on Monday said it had appointed Sri Ryali as CFO, effective immediately. The company said Ryali had most recently served as the CFO of Eiger BioPharmaceuticals ( EIGR ). Ryali also held positions in companies su...

REDWOOD CITY, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer effective immediately. Mr. Ryali brings 20 years of finance and commercial experience in life science...

REDWOOD CITY, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced an update on the Company’s ongoing plan to prioritize its time and resources on areas where the Company believes it has the strongest commercial...

REDWOOD CITY, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management will participate in a fireside chat at the Piper Sandler 34 th Annual Healthcare Conferen...

Summary Nothing's changed in our outlook for Codexis following its latest set of numbers. Guidance has been narrowed in key areas, and I note the retirement of several mid-term growth levers. Investors aren't rewarding cash flows priced into the future anymore, evidenced by th...

Codexis press release ( NASDAQ: CDXS ): Q3 GAAP EPS of -$0.15(vs. $0.03 Y/Y) beats by $0.04 . Revenue of $34.5M (-6.2% Y/Y) beats by $3.56M . FY22 Guidance: Total revenues are expected to be in the range of $135 million to $141 million. Consensus of $137.1...

REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced financial results for the third quarter ended September 30, 2022 and provided a business update. &...

Summary Baillie Gifford’s 13F portfolio value decreased from ~$97.51B to ~$96.99B this quarter. They increased Shopify, Roblox, Zoom Video, and Twilio while reducing Albemarle Corporation and Li Auto ADR. The top three positions are Tesla Motors, Moderna, and MercadoLib...

REDWOOD CITY, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that it will report its financial results for the third quarter of 2022 on Thursday, November 3, 2022, follow...

Summary ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. UiPath, Ginkgo Bioworks, and NVIDIA were increased while decreasing Spotify, Ionis Pharma, CRISPR Therapeutics, and Coinbase Global. The top three positions are Tesla Inc., Zoom Vid...